Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON28322Not yet recruiting
Randomised, open-label trial in Atrial fibrillation (AFib) (2 arms), sponsored by University Medical Center Groningen. Primary endpoints: Net clinical benefit, Stroke and 4 more. Planned start Nov 2014; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON28322.